Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the Tunnel

Hepatitis C virus (HCV) infection is a serious and growing threat to human health. The current treatment provides limited efficacy and is poorly tolerated, highlighting the urgent medical need for novel therapeutics. The membrane-targeted NS3 protein in complex with the NS4A comprises a serine prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatel-Chaix, Laurent, Baril, Martin, Lamarre, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185733/
https://www.ncbi.nlm.nih.gov/pubmed/21994705
http://dx.doi.org/10.3390/v2081752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185733/
https://www.ncbi.nlm.nih.gov/pubmed/21994705
http://dx.doi.org/10.3390/v2081752

Ejemplares similares